Asthma Medication Study

Now Enrolling People Ages 12 to 80 Years

● Now Enrolling

About this research study

Short-acting beta-antagonist (SABA) inhalers are one of the most widely used medications to relieve asthma symptoms. However, it is believed that they only treat the symptoms, not the cause (inflammation of the airways).

Velocity is now enrolling people with asthma who use SABA inhalers for a study of an investigational medication intended to provide rapid relief for asthma symptoms, while addressing underlying inflammation.

Eligible participants...

Must be age 12 or older and diagnosed with asthma
Must be regularly using a stable daily ICS/LABA regimen for at least 4 weeks
Will receive compensation for study-related time
Do not need insurance to join this study

For more information, complete the form on this page. After you submit your information, a Velocity enrollment specialist will call you to talk about the study. There is no obligation to participate — you can decide if the study is right for you.

More information about participating in a clinical trial...

After you submit your information, a Velocity enrollment specialist will contact you.

Participating in a study is an important decision — we’re here to help you before, during, and after studies.

Please note: Health insurance is NOT required to join.

Is participation voluntary after I submit my information?

Yes. Participation in a study is entirely voluntary. In the informed consent process, you’ll learn about the product being studied, the participant’s role in the study, potential side effects, the number of visits that may be required, and more. Participants must sign an informed consent form to join the study.

Will I receive compensation?

While participation in a clinical study is voluntary, you may be paid for study-related time. After you submit your information, a Velocity enrollment specialist will call you to talk about the study. Staff at the research clinic will discuss possible payment with you.

Enter your info

Name(Required)

Phone(Required)

Date of birth(Required)

Age can help us determine study eligibility (you must be age 18 or older to submit this form).

Month

Day

Year

Location and study of interest(Required)

Gender

Preferred language

Are you Hispanic or Latino?(Required)

Race(Required)

Select one or more designations that best describe you. This information can help Velocity better ensure all populations are represented in research.

American Indian or Alaskan Native

Asian

Black or African American

Native Hawaiian or Other Pacific Islander

White or Caucasian

This field is hidden when viewing the form

MobileOptIn

By entering your email address and/or phone number on this form, you represent that you are at least 18 years of age and consent to receiving communications (e.g., call, SMS, text, and/or email) from Velocity and/or the research site(s) involved with the clinical trials that appear on this website. Messaging frequency varies. Message and data rates may apply. You may reply with STOP to a text message. For any help regarding messaging, please email us at [email protected]. For full details, refer to Velocity's privacy policy and website terms of use. Submissions on this website are not monitored 24/7. Do NOT submit personal health or medical information on this form. If you are enrolled in a trial and have questions, please call your research site.

Name

This field is for validation purposes and should be left unchanged.

Study Locations

Anderson, South Carolina • Velocity Clinical Research

1214 N. Fant Street, Anderson, SC 29621
Phone: (864) 965-0190

Grants Pass, Oregon • Velocity Clinical Research

1867 Williams Hwy., Suite 109A, Grants Pass, OR 97527
Phone: (541) 237-0323

Lafayette, Louisiana • Velocity Clinical Research

401 Youngsville Hwy, Suite 100, Lafayette, LA 70508
Phone: (337) 451-0663

Rockville, Maryland • Velocity Clinical Research

1201 Seven Locks Road, Suite 214, Rockville, MD 20854
Phone: (240) 698-2800